Display options
Share it on

Diabetes Metab J. 2016 Feb;40(1):62-9. doi: 10.4093/dmj.2016.40.1.62.

The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults.

Diabetes & metabolism journal

Eun Hee Sim, Hye Won Lee, Hyun Ju Choi, Dong Wook Jeong, Seok Man Son, Yang Ho Kang

Affiliations

  1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
  2. Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
  3. Department of Family Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
  4. Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea. [email protected].

PMID: 26616596 PMCID: PMC4768052 DOI: 10.4093/dmj.2016.40.1.62

Abstract

BACKGROUND: Cystatin C has been known to be associated not only with early renal impairment but also with the incidence of diabetic conditions (prediabetes plus diabetes). However, it is not clear whether cystatin C levels are associated with the prevalence of diabetic conditions in Asian populations. We evaluated this association using glycosylated hemoglobin (HbA1c) levels as the definition of diabetes in Korean adults.

METHODS: We analyzed data from 1,559 Korean adults (937 men and 622 women) with available serum cystatin C and HbA1c values.

RESULTS: The serum cystatin C levels in subjects with prediabetes and diabetes were significantly increased (0.91±0.14 mg/L in prediabetes and 0.91±0.17 mg/L in diabetes vs. 0.88±0.13 mg/L in patients with normal glucose levels, P=0.001). At increasing cystatin C levels, the prevalence of subjects with prediabetes (30.2% vs. 14.6%, P<0.001) and those with diabetes (10.6% vs. 8.0%, P<0.001) significantly increased in the group with the highest cystatin C levels. The group with the highest cystatin C levels had a significantly increased odds ratio (OR) for the presence of diabetic conditions compared to the group with the lowest values in total subjects (OR, 2.35; 95% confidence interval [CI], 1.54 to 3.58; P<0.001) and in women (OR, 4.13; 95% CI, 1.97 to 8.65; P<0.001), though there was no significant increase after adjusting for multiple variables.

CONCLUSIONS: Higher levels of serum cystatin C are associated with an increased prevalence of diabetic conditions in Korean adults. Our findings may extend the positive association of cystatin C with diabetes incidence to an Asian population.

Keywords: Cystatin C; Diabetes mellitus; Hemoglobin A, glycosylated; Prediabetic state

References

  1. Clin Chem. 2007 Mar;53(3):480-8 - PubMed
  2. Atherosclerosis. 2010 Aug;211(2):660-6 - PubMed
  3. J Clin Hypertens (Greenwich). 2011 Dec;13(12):925-30 - PubMed
  4. Kidney Int. 2002 Apr;61(4):1453-61 - PubMed
  5. Diabetes Care. 2014 Jan;37 Suppl 1:S14-80 - PubMed
  6. Eur J Epidemiol. 2013 Apr;28(4):311-6 - PubMed
  7. J Korean Med Sci. 2011 Feb;26(2):258-63 - PubMed
  8. Diabetes Technol Ther. 2010 Nov;12(11):907-12 - PubMed
  9. Diabetologia. 2011 Jun;54(6):1335-40 - PubMed
  10. Clin Biochem. 2012 May;45(7-8):535-40 - PubMed
  11. Diabetes Care. 2007 Apr;30(4):854-60 - PubMed
  12. Diabetes Care. 2007 Jul;30(7):1724-9 - PubMed
  13. Metabolism. 2010 Feb;59(2):241-6 - PubMed
  14. Am J Med. 2005 Dec;118(12):1416 - PubMed
  15. Clin Chem. 2009 Nov;55(11):1932-43 - PubMed
  16. N Engl J Med. 2005 May 19;352(20):2049-60 - PubMed
  17. Diabetes Care. 2007 Feb;30(2):354-9 - PubMed
  18. Clin Biochem. 2005 Jan;38(1):1-8 - PubMed
  19. Biochimie. 2010 Nov;92(11):1580-6 - PubMed
  20. Am J Kidney Dis. 2000 Jul;36(1):29-34 - PubMed
  21. Clin Biochem. 2009 Jan;42(1-2):108-10 - PubMed
  22. Am J Med. 2008 May;121(5):426-32 - PubMed

Publication Types